Radioembolization Y-90 Alamogordo:
Liver cancer is the third most common cancer in the United States, and it’s considered to be one of the deadliest. In fact, liver cancer is so deadly that it now has a new hope: radioembolization. Radioembolization is a minimally invasive surgical procedure that uses tiny emboli (a type of particle) to destroy cancerous tumors in the liver. This new treatment has shown tremendous success in treating liver cancer patients, with an average survival rate of more than 90 percent. If you or someone you love is battling liver cancer, don’t hesitate to seek out radioembolization as your best hope for a successful outcome.
What is Radioembolization Y-90?
Radioembolization Y-90, also known as radiofrequency ablation or RF ablation, is a new and relatively painless treatment option for patients with liver cancer. The therapy uses heat to destroy cancerous tissue by causing tiny air bubbles to form and burst, destroying the tumor.
Unlike traditional surgery or radiation therapy, which can cause extensive pain and damage to surrounding tissues, RF ablation is minimally invasive. It can be performed through small incisions in the skin. This makes it an ideal option for patients who are reluctant to undergo traditional treatments or those who have difficulty traveling for care.
RF ablation is currently the only FDA-approved treatment for liver cancer, and its popularity has led to a shortage of physicians qualified to perform the procedure. However, thanks to advances in technology and the development of new treatments such as Y-90, there is now hope for thousands of liver cancer patients who would otherwise face an untenable prognosis.
How does Radioembolization Y-90 work?
Radioembolization Y-90 is a novel form of embolization that uses radiation to destroy cancerous tumors in the liver. The procedure is performed using a catheter that is passed through the patient’s bloodstream and into the tumor. The catheter is then filled with radioactive particles, and as the patient travels around, the particles heat up and damage the tumor.
What are the side effects of Radioembolization Y-90?
Radioembolization Y-90 is a new form of embolization that uses radio waves to stop blood flow to the tumor. The procedure is performed in a hospital setting and is often used to treat liver cancer.
Side effects of Radioembolization Y-90 are generally mild and include pain, bruising, bleeding, and infection. More serious side effects may include heart problems, nerve damage, or even death. It is important to discuss any potential side effects with your doctor before the procedure so that they can plan for them.
When is the best time to undergo Radioembolization Y-90 therapy?
Radioembolization Y-90 therapy is an FDA-approved treatment for liver cancer patients that can provide long-term relief from symptoms, according to the National Cancer Institute (NCI). The therapy uses radioactive material to block blood vessels in the liver, reducing the number of cancer cells able to reach other parts of the body.
There is no definitive answer to when is the best time to undergo Radioembolization Y-90 therapy, as it depends on a patient’s situation and health history. However, many patients find that this type of treatment works best when it is first started relatively early in the course of their cancer. This allows the therapy to have a greater impact on shrinking the tumor and limiting its ability to spread.
Some factors that may affect whether or not Radioembolization Y-90 therapy is right for a particular patient include the stage of their liver cancer; their overall health; Whether there are any other treatments being considered; and The availability of radiation facilities near where they live.
Radioembolization Y-90 Alamogordo is a new hope for liver cancer patients. At the 2013 American Society of Gastrointestinal and Liver Surgeons (ASGLS) Annual Meeting, doctors from across the country presented their findings on this promising new treatment. Radioembolization Y-90 uses tiny emboli to block blood flow to tumors, which shuts down the tumor’s ability to grow and spread. While radioembolization Y-90 is still in its early stages of development, many doctors are hopeful that it will become a more common treatment for liver cancer in the future.